Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Diseases of the Thyroid

  Free Subscription

Articles published in J Nucl Med

Retrieve available abstracts of 15 articles:
HTML format

Single Articles

    August 2021
  1. AVRAM AM, Zukotynski K, Nadel HR, Giovanella LM, et al
    J Nucl Med. 2021 Aug 19. pii: jnumed.121.262402. doi: 10.2967/jnumed.121.262402.
    PubMed     Abstract available

    July 2021
  2. GIOVANELLA L, Avram A, Clerc J
    Molecular Imaging for Thyrotoxicosis and Thyroid Nodules.
    J Nucl Med. 2021;62.
    PubMed     Abstract available

  3. BERNET VJ, Chindris AM
    Update on the Evaluation of Thyroid Nodules.
    J Nucl Med. 2021;62.
    PubMed     Abstract available

    March 2021
  4. SEIFERT R, Schafers MA, Heitplatz B, Kerschke L, et al
    Minimal extrathyroid extension in papillary micro carcinoma of the thyroid is an independent risk factor for relapse through lymph node and distant metastases.
    J Nucl Med. 2021 Mar 26. pii: jnumed.121.261898. doi: 10.2967/jnumed.121.261898.
    PubMed     Abstract available

    February 2021
  5. MARIANI G, Tonaccehra M, Grosso M, Fiore E, et al
    The Role of Nuclear Medicine in the Clinical Management of Benign Thyroid Disorders. Part 2. Nodular Goiter, Hypothyroidism, and Subacute Thyroiditis.
    J Nucl Med. 2021 Feb 12. pii: jnumed.120.251504. doi: 10.2967/jnumed.120.251504.
    PubMed     Abstract available

  6. BODET-MILIN C, Faivre-Chauvet A, Carlier T, Ansquer C, et al
    Anti-CEA pretargeted Immuno-PET shows higher sensitivity than DOPA-PET/CT to detect relapsing metastatic medullary thyroid carcinoma: Post- hoc analysis of the iPET-MTC study.
    J Nucl Med. 2021 Feb 5. pii: jnumed.120.252791. doi: 10.2967/jnumed.120.252791.
    PubMed     Abstract available

    October 2020
  7. MARIANI G, Tonacchera M, Grosso M, Orsolini F, et al
    The role of nuclear medicine in the clinical management of benign thyroid disorders. Part 1. Hyperthyroidism.
    J Nucl Med. 2020 Oct 2. pii: jnumed.120.243170. doi: 10.2967/jnumed.120.243170.
    PubMed     Abstract available

    July 2020
  8. GRIMALDI S, Lagarde S, Harle JR, Boucraut J, et al
    Autoimmune encephalitis concomitant with SARS-CoV-2 infection: insight from (18)F-FDG PET imaging and neuronal autoantibodies.
    J Nucl Med. 2020 Jul 24. pii: jnumed.120.249292. doi: 10.2967/jnumed.120.249292.
    PubMed     Abstract available

    May 2020
  9. CHENG L, Sa R, Luo Q, Fu H, et al
    Unexplained Hyperthyroglobulinemia in Differentiated Thyroid Cancer Patients Indicates Radioiodine Adjuvant Therapy: A Prospective Multicenter Study.
    J Nucl Med. 2020 May 1. pii: jnumed.120.243642. doi: 10.2967/jnumed.120.243642.
    PubMed     Abstract available

    April 2020
  10. PICCARDO A, Trimboli P, Bottoni G, Giovanella L, et al
    Radioiodine Ablation of Remaining Thyroid Lobe in Patients with Differentiated Thyroid Cancer Treated by Lobectomy. A systematic review and meta-analysis.
    J Nucl Med. 2020 Apr 24. pii: jnumed.120.244384. doi: 10.2967/jnumed.120.244384.
    PubMed     Abstract available

    March 2020
  11. DONOHOE KJ, Aloff J, Avram AM, Bennet KG, et al
    Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer.
    J Nucl Med. 2020;61:375-396.

  12. WU D, Gomes Lima CJ, Bloom G, Burman KD, et al
    Nationwide Survey on Implementation of 2011 Nuclear Regulatory Commission Policy on Release of Patients After (131)I Therapy for Thyroid Cancer.
    J Nucl Med. 2020;61:397-404.
    PubMed     Abstract available

    January 2020
  13. VERMANDEL M, Debruyne P, Beron A, Devos L, et al
    Management of patients with renal failure undergoing dialysis during (131)I therapy for thyroid cancer.
    J Nucl Med. 2020 Jan 10. pii: jnumed.119.232017. doi: 10.2967/jnumed.119.232017.
    PubMed     Abstract available

    October 2019
  14. GREENSPAN BS, Siegel JA, Hassan A, Silberstein EB, et al
    There is No Association of Radioactive Iodine Treatment with Cancer Mortality in Patients with Hyperthyroidism.
    J Nucl Med. 2019 Oct 4. pii: jnumed.119.235929. doi: 10.2967/jnumed.119.235929.

  15. CHEN W, Dilsizian V
    Radioactive Iodine Treatment and Cancer Mortality in Hyperthyroid Patients: Concerns with Study Design and Bias.
    J Nucl Med. 2019 Oct 4. pii: jnumed.119.234849. doi: 10.2967/jnumed.119.234849.

Thank you for your interest in scientific medicine.

AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.